BEAT-SHOCK: Baseline Registry for Acute Cardiogenic Shock at Basel

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

BEAT-SHOCK is an observational registry that documents patients with cardiogenic shock admitted to or developing during hospitalization at University Hospital Basel. The registry focuses on how acute cardiac failure and related conditions are managed, and how data are collected, stored, processed, and shared. It does not involve an experimental treatment, and there are no interventions being tested within the registry. Participation requires informed consent and adherence to data handling requirements. Findings from the registry may inform future clinical practice and research in cardiogenic shock and related conditions.

Why it matters

Who can join: the full rules

* Patients admitted with cardiogenic shock to the University hospital Basel (diagnosis at the time of admission) or development of cardiogenic shock during the hospital stay
* Age ≥18 years
* Provision of written ICF
* Clinical diagnosis of cardiogenic shock.
* impaired organ perfusion due to primary cardiac dysfunction,
* persistent systolic blood pressure (SBP) \<90 mmHg for ≥30 minutes, or the need for vasopressors, inotropes, or mechanical circulatory support (MCS) to maintain adequate perfusion and
* evidence of systemic hypoperfusion with arterial lactate ≥2 mmol/L or venous lactate ≥3 mmol/l and ≥1 of the following:
* Cold or clammy extremities
* Altered mental status
* Reduced urine output
* Signs of volume overload or congestion (on clinical exam, imaging, or invasive monitoring)
* Patients with normotensive cardiogenic shock (SBP ≥90 mmHg without vasopressors or MCS) may also be included if clear signs of hypoperfusion (arterial lactate ≥2 mmol/L or venous lactate ≥3 mmol/l) and cardiac dysfunction are present and alternative causes are excluded

Exclusion criteria:

* Age \<18 years
* Refusal to provide informed consent by the patient or their legally authorized representative

Where it's running

• University Hospital Basel
  Basel, Canton of Basel-City, Switzerland Recruiting

Study contacts

• Study coordinator: Jasper Boeddinghaus, PD Dr. med.
• Email: jasper.boeddinghaus@usb.ch
• Phone: 0041613287897

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Evaluating a noninvasive tissue sensor to detect cardiogenic shock earlier in heart patients

  This pilot, noninvasive study tests whether the NIRSense wearable can help detect deterioration in adults with cardiogenic shock risk due to heart attack or heart failure.

  Recruiting NIRSense Inc. · Weston, Florida · NCT07825363

• Registry of patients with acute cardiovascular disease in a cardiac intensive care unit

  This study is looking at patients with serious heart conditions in the Cardiac Intensive Care Unit to see how they do during and after their hospital stay.

  Recruiting University Hospital, Ioannina · Ioannina, Epirus · NCT06081205

• Factors Influencing Outcomes in ECMO and Impella Patients

  This study tests whether metabolic and thyroid hormone changes help predict survival for adults on ECMO or Impella at a single Hungarian cardiac ICU.

  Recruiting Gottsegen National Cardiovascular Institute · Budapest · NCT07885618

• Risk of malignant arrhythmias after acute coronary syndrome

  This study tracks how often dangerous heart rhythms occur in adults admitted for ACS and looks for patterns that might predict them.

  Recruiting Catharina Ziekenhuis Eindhoven · Eindhoven, North Brabant · NCT07824050

• Smartphone AI help for prehospital ECG readings

  This study tests whether using a smartphone AI (GPT-4o) to help prehospital providers read 12-lead ECGs improves accuracy in diagnosing acute coronary syndromes and related conditions.

  Recruiting École Supérieure de Soins Ambulanciers - College of Higher Education in Prehospital Care · Murten/Morat, Canton of Fribourg · NCT07810686

• Safety and Efficacy of an Extracorporeal Ventricular Assist System for Cardiogenic Shock

  This study tests whether an extracorporeal ventricular assist device can safely provide short-term heart support and help patients with cardiogenic shock or trouble weaning from bypass.

  Recruiting China National Center for Cardiovascular Diseases · Beijing, Beijing Municipality · NCT07769528

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.